Home  |  Contact

UniProtKB/Swiss-Prot Q99972: Variant p.Ala363Thr

Myocilin
Gene: MYOC
Variant information

Variant position:  363
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Alanine (A) to Threonine (T) at position 363 (A363T, p.Ala363Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and hydrophobic (A) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In GLC1A.
Any additional useful information about the variant.



Sequence information

Variant position:  363
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  504
The length of the canonical sequence.

Location on the sequence:   TVIRYELNTETVKAEKEIPG  A GYHGQFPYSWGGYTDIDLAV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         TVIRYELNTETVKAEKEIPGAGYHGQFPYSW------GGYTDIDLAV

                              TVVRYELTAETVKAEREIPGAGYHGQFPYSW------GGYT

Mouse                         TVVRYELDTETVKAEKEIPGAGYHGHFPYAW------GGYT

Rat                           TVLRYELNTETVKAEKEIPGAGYHGQFPYAW------GGYT

Bovine                        TVLRYDLRTETLKAEKEIPGAGYHGQFPYSW------GGYT

Rabbit                        TVIRFELNTETVKAEKEIPGAGYRGQFPYSW------GGYT

Cat                           TVIRYELNTETVKAEKEIPGAGYHGQFPYSW------GGYT

Slime mold                    VAVTTEFKTELVALINKQKGTTLAVNFGQSIQYFKKKGSNN

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 33 – 504 Myocilin
Chain 227 – 504 Myocilin, C-terminal fragment
Domain 244 – 503 Olfactomedin-like
Metal binding 380 – 380 Calcium
Disulfide bond 245 – 433


Literature citations

Novel mutations in the myocilin gene in Japanese glaucoma patients.
Kubota R.; Mashima Y.; Ohtake Y.; Tanino T.; Kimura T.; Hotta Y.; Kanai A.; Tokuoka S.; Azuma I.; Tanihara H.; Inatani M.; Inoue Y.; Kudoh J.; Oguchi Y.; Shimizu N.;
Hum. Mutat. 16:270-270(2000)
Cited for: VARIANTS GLC1A GLN-158; ASN-360 AND THR-363; VARIANTS HIS-19; LYS-76; GLU-208 AND HIS-470;

Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography.
Ishikawa K.; Funayama T.; Ohtake Y.; Tanino T.; Kurosaka D.; Suzuki K.; Ideta H.; Fujimaki T.; Tanihara H.; Asaoka R.; Naoi N.; Yasuda N.; Iwata T.; Mashima Y.;
J. Glaucoma 13:466-471(2004)
Cited for: VARIANTS GLC1A ASN-360; THR-363; LEU-369 AND PRO-448;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.